Over the past 12 months, 5 insiders at PepGen Inc. filed 8 open-market SEC Form 4 transactions on PEPG: 2 purchases worth $30.6M and 6 sales worth $58K. Insiders have been net sellers over this period. The most recent filing was on Mar 4, 26.
| Date | Insider | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 4, 26 | Noel DonnellyChief Financial Officer | SELL | 2.0K | $6.33 | $13K |
| Mar 4, 26 | James G McArthurPresident and CEO | SELL | 5.1K | $6.33 | $32K |
| Mar 4, 26 | Paul StreckEVP, Head of R&D | SELL | 1.8K | $6.29 | $11K |
| Sep 30, 25 | Oxford Science Enterprises PlcOther | BUY | 200.0K | $3.20 | $640K |
| Sep 26, 25 | Ra Capital Healthcare Fund LpDirector,TenPercentOwner | BUY | 9.38M | $3.20 | $30.0M |
| May 30, 25 | Paul StreckEVP, Head of R&D | BUY | 8.4K | $1.24 | $10K |
| Apr 17, 25 | James G McArthurPresident and CEO | BUY | 10.0K | $1.36 | $14K |
| Apr 8, 25 | James G McArthurPresident and CEO | BUY | 41.5K | $1.15 | $48K |
| Feb 26, 25 | Mary Beth DelenaGeneral Counsel | SELL | 1.4K | $1.68 | $2K |
| Feb 26, 25 | Noel DonnellyChief Financial Officer | SELL | 1.5K | $1.68 | $3K |
| Jul 25, 24 | Michelle L MellionChief Medical Officer | SELL | 7.6K | $18.06 | $137K |
| Jul 24, 24 | Michelle L MellionChief Medical Officer | SELL | 201 | $18.01 | $4K |
| Jul 18, 24 | Michelle L MellionChief Medical Officer | SELL | 12.6K | $18.20 | $230K |
| Jul 16, 24 | Michelle L MellionChief Medical Officer | SELL | 5.9K | $18.00 | $106K |
| Jul 12, 24 | Michelle L MellionChief Medical Officer | SELL | 3.3K | $18.04 | $59K |
| Jul 2, 24 | Michelle L MellionChief Medical Officer | SELL | 37 | $18.07 | $669 |
| Jul 1, 24 | Michelle L MellionChief Medical Officer | SELL | 875 | $18.01 | $16K |
| Jun 24, 24 | Michelle L MellionChief Medical Officer | SELL | 9.3K | $18.19 | $168K |
| Jun 12, 24 | Michelle L MellionChief Medical Officer | SELL | 1.1K | $18.06 | $20K |
| Jun 11, 24 | Michelle L MellionChief Medical Officer | SELL | 500 | $18.04 | $9K |
| Jun 6, 24 | Michelle L MellionSVP, Clinical Development | SELL | 1.4K | $18.00 | $25K |
| Jun 5, 24 | Michelle L MellionSVP, Clinical Development | SELL | 7.2K | $18.09 | $131K |
| May 17, 24 | Niels SvenstrupSVP, Chem. Mfg & Controls | SELL | 10.0K | $13.41 | $134K |
| Feb 9, 24 | Peter KolchinskyDirector,TenPercentOwner | BUY | 2.56M | $10.64 | $27.2M |
| Nov 30, 23 | James G McArthurPresident and CEO | BUY | 1.7K | $4.17 | $7K |
| Jun 8, 23 | James G McArthurPresident and CEO | SELL | 2.4K | $16.04 | $38K |
| Jun 7, 23 | James G McArthurPresident and CEO | SELL | 8.4K | $16.23 | $137K |
| Jun 6, 23 | James G McArthurPresident and CEO | SELL | 18.1K | $16.18 | $294K |
| Jun 5, 23 | James G McArthurPresident and CEO | SELL | 500 | $16.06 | $8K |
| Jun 2, 23 | James G McArthurPresident and CEO | SELL | 1.8K | $16.04 | $29K |
| Mar 24, 23 | Jaya GoyalEVP, Res. & Preclin. Dev. | SELL | 392 | $20.00 | $8K |
| Feb 8, 23 | Jaya GoyalEVP, Res. & Preclin. Dev. | SELL | 644 | $17.00 | $11K |
| Feb 7, 23 | Jaya GoyalEVP, Res. & Preclin. Dev. | SELL | 3.7K | $17.18 | $63K |
| Feb 6, 23 | Jaya GoyalEVP, Res. & Preclin. Dev. | SELL | 1.7K | $17.04 | $29K |
| May 10, 22 | Deerfield Private Design Fund V, L.p.TenPercentOwnerOther | BUY | 208.3K | $12.00 | $2.5M |
| May 10, 22 | Peter KolchinskyDirector,TenPercentOwner | BUY | 2.98M | $12.00 | $35.8M |
| May 10, 22 | Oxford Science Enterprises PlcTenPercentOwner | BUY | 880.0K | $12.00 | $10.6M |
| May 6, 22 | Laurie KeatingDirector | BUY | 4.2K | $12.00 | $50K |
Over the past 12 months, insiders at PepGen Inc. filed 2 open-market purchases worth $30.6M and 6 sales worth $58K on PEPG, which makes them net sellers over the period. The most recent Form 4 was filed on Mar 4, 26.
The largest recent open-market PEPG insider purchase in our data was $35.8M by Peter Kolchinsky, Director,TenPercentOwner, filed on May 10, 22.
5 different insiders at PepGen Inc. filed open-market SEC Form 4 transactions on PEPG over the last 12 months.
InsiderTape plots every PEPG insider buy and sell directly on the price chart and flags new SEC Form 4 filings as they arrive, with cluster detection and buy/sell pressure. The data updates daily from SEC EDGAR.
InsiderTape plots every PepGen Inc. insider buy and sell on the price chart, with buy/sell pressure, cluster detection, and alerts the moment new Form 4s hit. Start a free 7-day trial, cancel anytime.
Does it work? In five years of data, insider clusters beat the Russell 2000 about 60% of the time and the CFO's buy was the sharpest signal of all. See the backtest →
START FREE TRIAL →